SEC Comment Letter 0000000000-24-009468 to DURECT CORP (DRRX) (CIK 0001082038)
DURECT CORP (DRRX) (CIK 0001082038)
Date: Aug. 19, 2024 · CIK: 0001082038 · Accession: 0000000000-24-009468
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281550
Letter
August 19, 2024 James E. Brown Chief Executive Officer DURECT Corporation 10240 Bubb Road Cupertino, California 95014 Re:DURECT Corporation Registration Statement on Form S-3 Filed August 14, 2024 File No. 333-281550 Dear James E. Brown: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Stephen B. Thau
Show Raw Text
August 19, 2024
James E. Brown
Chief Executive Officer
DURECT Corporation
10240 Bubb Road
Cupertino, California 95014
Re:DURECT Corporation
Registration Statement on Form S-3
Filed August 14, 2024
File No. 333-281550
Dear James E. Brown:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Stephen B. Thau